Cost-Effectiveness Analysis Of Daclatasvir/Sofosbuvir (DCV/SOF) For The Treatment Of HCV Patients Who Failed After First Line Treatment With Second Generation Of Daa In Italy
Abstract
Authors
M Ruggeri FR Rolli S Coretti L Kondili F De Solda C Nappi A Cicchetti